Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1–44)] in type 2 (non-insulin-dependent) diabetes
Richards, N. T. ; Wood, S. M. ; Christofides, N. D. ; Bhuttacharji, S. C. ; Bloom, S. R.
Springer
Published 1984
Springer
Published 1984
| ISSN: |
1432-0428
|
|---|---|
| Keywords: |
Diabetes ; growth hormone releasing factor
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Summary Human pancreatic growth hormone releasing factor [GRF(1–44)] is the largest molecule of several peptides recently isolated from pancreatic tumours associated with acromegaly. It has been shown to stimulate the release of growth hormone in normal subjects and provides a safe and reliable tool for examining growth hormone release. A study was conducted to examine the release of growth hormone in patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes. GRF(1–44) stimulated the release of growth hormone in normal subjects and produced no side effects. A response of similar magnitude occurred in Type 1 diabetic patients despite their concomitant hyperglycaemia. In contrast, the response in Type 2 diabetes was significantly impaired compared with normal volunteers (p〈0.05) and Type 1 diabetic patients (p〈0.02). These findings may well indicate that there is a defect in central hormonal control in Type 2 diabetes.
|
| Type of Medium: |
Electronic Resource
|
| URL: |